Document is current
Any future updates will be listed below
-
Authors
Arneson, Adriana
Haghani, Amin
Thompson, Michael J. https://orcid.org/0000-0002-2914-1080
Pellegrini, Matteo
Kwon, Soo Bin https://orcid.org/0000-0002-8670-0993
Vu, Ha
Maciejewski, Emily
Yao, Mingjia
Li, Caesar Z. https://orcid.org/0000-0002-3907-7983
Lu, Ake T.
Morselli, Marco https://orcid.org/0000-0003-3351-5791
Rubbi, Liudmilla
Barnes, Bret
Hansen, Kasper D.
Zhou, Wanding
Breeze, Charles E. https://orcid.org/0000-0002-5294-915X
Ernst, Jason https://orcid.org/0000-0003-4026-7853
Horvath, Steve https://orcid.org/0000-0002-4110-3589
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP1DA044371)
National Science Foundation (1254200)
UCLA Jonsson Comprehensive Cancer Center and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Ablon Scholars Program
Paul G. Allen Family Foundation
- License Information
-
More Information
Article History
Received: 15 November 2021
Accepted: 20 January 2022
First Online: 10 February 2022
Competing interests
: The Regents of the University of California filed a patent application (publication number WO2020150705) related to this work for which A.A., B.B., J.E. and S.H. are named inventors. S.H. is a founder of the non-profit Epigenetic Clock Development Foundation, which has licensed several patents from his employer UC Regents, and distributes the mammalian methylation array. Bret Barnes is an employee for Illumina Inc which manufactures the mammalian methylation array. The remaining authors declare no competing interests.
